• Republic Healthcare agreed to sell its entire stake in Life Ark (Shenzhen) Technology to Shenzhen Ronghui Renhe Life Technology Group for RMB 13.7 million cash.
• Payment due by Dec. 31, 2026; completion targeted for Aug. 31, 2026, when the buyer is registered as shareholder.
• Target will deconsolidate on closing; proceeds earmarked for working capital, potential future acquisitions, investments.
• Group expects an unaudited disposal gain of about RMB 7.96 million, based on a May 31, 2026 net asset value of RMB 5.74 million.
• Sale follows tighter PRC rules for clinical research and applications; target posted a 2025 loss before tax of RMB 4.24 million.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Republic Healthcare Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260731-12264628), on July 31, 2026, and is solely responsible for the information contained therein.